Physician profile
Aaron Mcpeek
NPI 1063875250
$2,619.57
in general payments reported to CMS, 2019-2025
24 companies · $923 in 2025
The $923 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.60 · 2021: $56.36 · 2022: $408 · 2023: $242 · 2024: $950 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $686.24 | 2022-2025 | Proclaim, Octrode, Eterna |
| Saluda Medical Americas, INC. | $390.98 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $289.57 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $257.84 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $145.59 | 2024-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $144.32 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $103.33 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.93 | 2024-2025 | Relistor |
| Abbvie INC. | $92.97 | 2024-2025 | |
| Electronic Waveform Lab, INC. | $56.49 | 2024 | |
| Redhill Biopharma INC. | $41.61 | 2021 | |
| Medtronic USA, INC. | $39.60 | 2020 | |
| Scilex Pharmaceuticals INC. | $37.25 | 2022-2024 | |
| Curonix LLC | $32.92 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Horizon Therapeutics Plc | $27.76 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $26.14 | 2025 | Spinraza |
| Spinal Simplicity, LLC | $24.50 | 2025 | Ha Minuteman G3-R |
| Nevro Corp. | $24.01 | 2024 | Senza |
| International Rehabilitative Sciences, INC | $19.48 | 2024 | Rs-4i Plus Sequential Stimulator |
| Convatec INC. | $18.88 | 2024 | |
| Vertos Medical, INC. | $18.48 | 2024 | Mild Device Kit |
| Pfizer INC. | $16.66 | 2023 | |
| Protega Pharmaceutials INC | $15.80 | 2024 | Roxybond |
| Grt US Holding, INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Mcpeek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.